The Big Health Debate pitched Conservatives, Labour and Lib Dems against each other – and a roomful of frontline staff worried about an overstretched NHS
The latest Pharmaceutical Price Regulation Scheme (PPRS) is barely into its second year of operation but with rising payments to the Department of Health (DH) confirmed at the end of the first
England's health service is raising awareness of cancer and working with medical device firm Covidien to launch a cheaper and faster diagnostic to help tackle oesophago-gastric cancers.
pharmaphorum spoke to Tom Lindley, the head of Commercial Development at Yorkshire and Humber AHSN, about the organisation and how it is pushing forward innovation in the NHS.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
